BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 139 filers reported holding BIOSCRIP INC in Q3 2014. The put-call ratio across all filers is 6.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $5,286,000 | -69.1% | 1,193,308 | -51.2% | 0.21% | -56.8% |
Q4 2014 | $17,081,000 | +8.4% | 2,443,668 | +7.2% | 0.48% | -3.4% |
Q3 2014 | $15,751,000 | -9.9% | 2,279,426 | +8.8% | 0.50% | -11.4% |
Q2 2014 | $17,472,000 | +37.7% | 2,094,917 | +15.2% | 0.56% | +25.0% |
Q1 2014 | $12,690,000 | -9.9% | 1,818,117 | -4.5% | 0.45% | +11.7% |
Q4 2013 | $14,083,000 | +1223.6% | 1,903,107 | +1471.0% | 0.40% | +1013.9% |
Q3 2013 | $1,064,000 | -82.2% | 121,140 | -66.6% | 0.04% | -80.0% |
Q2 2013 | $5,989,000 | – | 362,977 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |